25 Jul 2021

Scientific Briefing - Probing the Source of Unstable Impurity and Controlling its Formulation at Release

PDF 835 kB
Content provided by our supplier

Adare Pharma Solutions

  • US
  • 2015
    On CPHI since
  • 2
  • 500 - 999
Company types
Contract Service
Packaging supplier/manufacturer
Primary activities
Contract Manufacturer
Out-licensing specialist
Packaging & drug delivery

Other Content from Adare Pharma Solutions (4)

  • News A Start-Up’s Guide to Choosing Their First CDMO: Breakfast Session Bulletin

    Throughout CPHI North America 2023, several Breakfast Sessions were held to start the day off right with a complimentary breakfast and a networking and learning session for our attendees. With insightful presentations from industry experts and partners, the CPHI North America Breakfast Sessions had something for everyone looking to fill their brains and their stomachs. 
  • News CPHI North America 2023 – From the Floor

    Follow along for live updates from the Content team as we bring you the latest from CPHI North America 2023 - from session talks, panel discussions, interviews, and more, there's a lot to discover with CPHI Online at the Pennsylvania Convention Center! 
  • Video A Guide to Successful Collaboration - Considerations When Choosing Your First CDMO as a Start-Up

    In pharma, it is essential to identify the right partner to ensure a successful outcome. Time and time again, mistakes have been made in this process, causing clinical studies to fail and for the company to take a heavy hit. Want to avoid this? join our one-hour masterclass where we will devise a checklist for choosing your first CDMO. Discussion Points Thinking ahead before executing – why it is essential to map out what you need to achieve in all departments Why creating a business partnership case to potential CDMOs will determine if they are the right fit for you A checklist of the common pitfalls and how to avoid
  • News Adare Pharma acquires oral formulations specialist Frontida BioPharm

    The combined company intends to lead in the space of oral formulations, solving customers' complex formulation challenges